Indications
For temporary relief of fever and minor inflammation.
Pleo Rec
FDA Label NDC 60681-3104
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Sanum Kehlbeck Gmbh & Co. Kg for the product Pleo Rec (NDC 60681-3104). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding indications, active ingredient per dose, inactive ingredients, dosage, warning, tamper evident, principal display panel - 10 suppository carton, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Active Ingredient Per Dose
0.2 g Bacillus firmus 6X.
Inactive Ingredients
hydrogenated palm kernel glycerides, lactose.
Dosage
1–3 times weekly, insert one suppository rectally at bedtime.
Warning
If symptoms persist more than a few days, contact a licensed practitioner. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health care professional before using this product.
Tamper Evident
Use this product only if inner blister pack is intact.
Principal Display Panel - 10 Suppository Carton
Pleo™ Rec
SUPPOSITORIES 6X
Homeopathic Fever
Reducer Medicine
Indications: For temporary relief
of fever and minor inflammation.
10 SUPPOSITORIES
Principal Display Panel (10 Suppository Carton)
* Please review the disclaimer below.
